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Serine proteases belonging to the kallikrein group may play a central role in desquamation. We have identiﬁed
human kallikreins 5, 7, and 14 (hK5, hK7, hK14) in catalytically active form in stratum corneum. All three enzymes
are produced as inactive precursors. In this work, we prepared recombinant enzymes and enzyme precursors and
characterized the catalytic properties of hK5 and hK14. With peptide substrates hK5 and hK14 both showed trypsin-
like speciﬁcity and alkaline pH-optima. For the substrates tested, hK14 was superior to hK5 as regards maximum
catalytic rate as well as catalytic efﬁciency. hK5, but not hK14, could activate pro-hK7 in a reaction which was
optimal at pH 5–7. hK5 could activate its own precursor as well as pro-hK14. This was in contrast to hK14, which
could activate pro-hK5 but not its own precursor. The activation of pro-hK5 either by auto-activation or by hK14
occurred at maximum rate at neutral or weakly alkaline pH, whereas activation of pro-hK14 by hK5 was optimal at
pH 6–7. We conclude that the enzymes studied may be part of a protease cascade in the stratum corneum, and that
the observed pH effects may have physiological relevance.
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In simplistic terms, the stratum corneum can be described
as a stockade made up by corneocytes held together by
corneodesmosomes and surrounded by lipids. Its continu-
ous production as a result of epidermal differentiation is
balanced by desquamation. Regulated transition from a
state of strong intercellular cohesion in deeper layers to a
state where individual cells are being shed at the skin sur-
face implies a well-tuned proteolytic degradation of adhe-
sive structures. The responsible proteolytic system may be
predicted to consist of pro-enzymes, enzymes, enzyme ac-
tivators, and inhibitors. Since corneocytes are non-viable,
production and deposition of these components must take
place before or concomitant with the cornification process.
This ‘‘proteolytic programming’’ of the stratum corneum,
most likely of central importance for epidermal home-
ostasis, is still far from being fully understood (Egelrud,
2000).
The stratum corneum has been shown to contain several
proteases with suggested roles in desquamation. To these
belongs a thiol protease (Watkinson, 1999) as well as the
aspartic protease Cathepsin D (Horikoshi et al, 1998). In
addition stratum corneum contains a number of serine pro-
teases, recently shown to belong to the kallikrein family
(Komatsu et al, 2003). We have presented evidence that
stratum corneum chymotryptic enzyme (SCCE; human
kallikrein 7; hK7) as well as stratum corneum tryptic en-
zyme (SCTE; hK5) may both be involved in the desquamat-
ion process (Egelrud and Lundstro¨m, 1991; Lundstro¨m and
Egelrud, 1991; Egelrud, 1993; Ekholm et al, 2000; Caubet
et al, 2004).
Quantification of proteases based on enzyme activity
yields different results depending on which assay system is
used. When extracts of stratum corneum are analyzed with
casein zymography hK5 and hK7 appear to be the two
dominating enzymes, responsible for essentially all detect-
able activity in crude extracts (Lundstro¨m and Egelrud,
1991). With chromogenic peptide substrates essentially all
chymotrypsin-like activity can be ascribed to hK7 (Egelrud,
1993). With chromogenic peptide substrates for trypsin-like
enzymes, on the other hand, we recently found that at most
50% of the total activity in stratum corneum extracts was
due to hK5, whereas a major part of the remaining activity
was associated with an enzyme that, after purification and
amino acid sequence analysis, could be identified as hK14
(manuscript in preparation).
We have previously shown that hK5 and hK7 are both
present in stratum corneum extracts in active as well as
precursor forms (Ekholm et al, 2000). This raises the pos-
sibility that zymogen activation may be an important part of
the regulation of mechanisms in the stratum corneum de-
pendent on proteolysis, including desquamation. Enzymes
present in the tissue may form a proteolytic cascade in
which already activated enzymes serve as activators of pre-
cursors of other enzymes, resulting in amplification effects
as well as a multitude of targets for regulatory influences. In
this work we investigated hK5 and hK14 with regard to their
catalytic properties and their ability to act as activators of
their own and each other’s precursors as well as of pro-hK7.
Results
Purified recombinant proteins from insect cells showed
some heterogeneity, probably due to variations in degree
of glycosylation (Fig 1). Production of catalytically active
Abbreviations: hK, human tissue kallikrein protein; KLK, tissue
kallikrein gene; PAGE, polyacrylamide gel electrophoresis
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enzymes was verified by activity measurements with
chromogenic peptide substrates and casein zymography,
and by the appearance of new components with expected
molecular masses (Fig 1). hK14 protein produced by insect
cells was catalytically inactive if not treated with an acti-
vating enzyme whereas hK14 produced in the yeast system
showed full catalytic activity after purification. This was
most likely due to post-translational removal of the propep-
tide, as suggested by amino acid sequence analyses (not
shown). The yield of the two variants of pro-hK5, and of pro-
hK14 from transfected insect cells was in the range of 1–5
mg per liter of conditioned growth medium. Around 15 mg
of hK14 protein per liter of medium was obtained from yeast
cells. No difference in activity between hK14 protein with or
without tag, produced in insect or yeast cells, could be de-
tected (data not shown).
Activity toward chromogenic peptide substrates The
catalytic properties of hK5 and hK14 toward a set of
chromogenic peptide substrates are shown in Table II.
Trypsin was included for comparison. Although S-2586 is a
substrate for chymotrypsin-like proteases, the other subst-
rates tested (see Table I for structures) are all substrates for
enzymes with trypsin-like primary substrate specificity. As
predicted by their amino acid sequence, hK5 and hK14 both
preferentially cleave trypsin-like substrates. In contrast to
hK5, hK14 also had a low but significant chymotryptic ac-
tivity. Comparison of hK5 and hK14 showed that hK14 was
superior for all substrates tested. The difference in maxi-
mum catalytic rate (kcat) was smallest, around 10-fold, with
S-2302, and largest, around 80-fold, with S-2288. hK14 was
even more superior to hK5 when catalytic efficiency (kcat/
Km) were calculated. When we compared hK14 and trypsin
we found that kcat for the two enzymes were of the same
order of magnitude with substrates S-2288 and S-2302, but
two orders of magnitude higher for trypsin with S-2222.
When Km values were taken into account in addition to kcat,
trypsin was much more efficient than hK14 toward all three
substrates (Table II).
With chromogenic peptide substrates hK5 and hK14
both had maximum activity at pH 8–9 (Fig 2). The pH profile
of hK14 differed slightly from that of hK5; hK14 having an
activity versus pH curve that was skewed toward weakly
acidic pH.
The effects of various inhibitors on hK5 and hK14 are
shown in Table III. Aprotinin, zinc sulfate, soybean trypsin
inhibitor, and leupeptin all inhibited both enzymes with high
and approximately similar efficiencies. Also chymostatin
could inhibit hK14, although with an IC50 that was around
one order of magnitude higher than for leupeptin. Chy-
mostatin had no effect on the activity of hK5 at the con-
centrations tested.
Activation of pro-hK7 Since the propeptide of pro-hK7
ends with a tryptic cleavage site (Table IV), and activation
can be obtained by treatment of the pro-enzyme with pan-
creatic trypsin (Hansson et al, 1994), we wanted to elucidate
whether hK5 and hK14 could act as pro-hK7 activators.
Activation was followed by measuring activity toward the
substrate S-2586, by immunoblotting and by casein gel
zymography. hK14 could not activate pro-hK7 at any con-
dition tested. This was in contrast to hK5, which could
convert inactive precursor to catalytically active hK7 at a
slow but significant rate (Fig 3A). The expected shift in mo-
lecular mass, suggesting removal of the pro-peptide from
pro-hK7 by incubation with hK5, could be confirmed by
immunoblotting (Fig 3B). Activation was confirmed also by
zymography (data not shown). At molar ratio 1:1 30%–40%
of pro-hK7 was converted to active enzyme after 24 h in-
cubation (based on densitometric scanning of immunoblots,
cf lane 3, Fig 3). The activation reaction had an acidic pH
optimum (pH 5–7; Fig 4A). Control experiments showed that
this could not be explained by decreased stability of hK5 at
higher pH values (data not shown).
Activation of pro-hK5 When purified native recombinant
pro-hK5 was incubated without any additions at 371C, pH
8.0, and its activity toward the substrate S-2302 measured
at different time points, there was a time-dependent in-
crease in catalytic activity. When activity was plotted
against time a sigmoid curve was obtained, suggesting au-
to-activation. This could be confirmed by incubating pro-
hK5 with small amounts of active hK5 (Fig 5A). The rate of
auto-activation of hK5 was maximal at pH values around 8
(Fig 4B). Activation of pro-hK5 was efficiently catalyzed by
hK14 (Fig 5A) with maximum rate at pH 7–9 (Fig 4C). On a
molar basis hK14 appeared to be approximately 50-fold
more efficient than hK5 in activating pro-hK5 (Fig 5A).
Activation of pro-hK14 Recombinant pro-hK14 could be
readily activated by hK5 (Fig 5B). As for pro-hK7, activation
of pro-hK14 by hK5 occurred at maximum rate at slightly
acidic pH (Fig 4D). We found no evidence of efficient auto-
Figure 1
Preparations of recombinant human tissue kallikrein protein (hK)5
and hK14; precursors and active enzymes. SDS-PAGE, coomassie
staining. From left to right: Mutated pro-hK5 (proEK-hK5) and hK5EK
activated by enterokinase treatment; wild-type pro-hK5 (pro-hK5) and
hK5 activated by auto-activation; pro-hK14 and hK14 produced in in-
sect cells and activated by enterokinase treatment, without and with
tag (pro-hK14V5His, hK14V5His); hK14 produced in Pichia pastoris
(hK14P).
Table I. Structures of chromogenic substrates
Substrate Amino acid sequence
S-2288 H-D-Ile-Pro-Arg-pNA  2HCl
S-2222 Bz-Ile-Glu(g-OR)-Gly-Arg-pNA HCl
S-2302 H-D-Pro-Phe-Arg-pNA 2HCl
S-2586 MeO-Suc-Arg-Pro-Tyr-pNA HCl
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activation of hK14, neither when pro-hK14 was incubated
alone for prolonged periods of time, nor when the precursor
was incubated with previously activated hK14 (Fig 5B
and C).
Discussion
The number of human serine proteases for which a specific
physiological function has not yet been elucidated is very
large. This holds true also for the 15 kallikreins encoded by
genes clustered in a small part of chromosome 19
(19q13.3–q13.4). With sensitive RNA-techniques expres-
sion of the majority of the kallikreins can be detected in
most tissues, including skin (Clements et al, 2001; Yousef
and Diamandis, 2001; Komatsu et al, 2003). So far it has
been assumed that the high expression of, e.g., hK5 and
hK7 in keratinizing epithelia, as compared with other tis-
sues, is reflecting a specific function of these enzymes in
processes involved in the formation and turnover of corni-
fied keratinocytes (Sondell et al, 1996; Ekholm et al, 2000;
Hansson et al, 2002). This does not exclude, however, the
possibility that hK5 and/or hK7 may have specific functions
in other tissues (Tanimoto et al, 1999; Dong et al, 2003).
Similarly, other serine proteases, including kallikreins, which
are expressed at low levels in the epidermis, may exert im-
portant functions in the skin. In this work we have concen-
trated on the three human kallikreins that have so far been
identified in catalytically active form in the stratum corneum.
Our aim, besides elucidating basic catalytic properties of
hK5 and hK14, was to investigate possible functions of hK5
and hK14 as activators of each other and of pro-hK7. The
precursors of hK5 and hK7 can both be converted to active
Table II. Kinetic parameters of recombinant human tissue kallikrein protein (hK)5,
hK14 and trypsin
Enzymea Substrateb
Enzyme
concentrationc
(nM)
Km
(mM)
Vmax
(nM per s)
kcat
(per s)
kcat/Km
(per sper M)
rhK5 S-2288 150 0.7 6.0 4.0  102 5.7  101
S-2222 150 0.5 1.6 1.1  102 2.2  101
S-2302 150 2.4 28 1.9  101 7.9  101
S-2586 150 – – – –
rhK14 S-2288 10.3 0.3 32 3.1 1.0  104
S-2222 10.3 0.2 3.2 3.1  101 1.5  103
S-2302 10.3 0.2 24 2.3 1.2  104
S-2586 650 0.7 37 5.7  102 8.1  101
Trypsin S-2288 0.42 0.008 5.7 14 1.8  106
S-2222 0.42 0.04 11 26 6.5  105
S-2302 1 0.04 3.5 3.5 8.8  104
S-2586 nd nd nd nd nd
ahK5 and tagged hK14 were produced in insect cells and activated by recombinant enterokinase.
bSee Table I for structures.
cEnzyme concentration was calculated from three or more active site titration for each prepa-
ration.
–, no enzyme activity could be detected.
nd, not determined.
Values for Km and Vmax represent means of results from at least three separate experiments.
Figure 2
Effect of pH on the activity of human tissue kallikrein protein (hK)5
and hK14 towards S-2302. In a total volume of 82.5 mL, 350 ng of hK5
(auto-activated wild-type; A) or 6.25 ng hK14 (produced in Pichia pas-
toris; B) was incubated at 371C in universal buffer (Britton and Welford,
1937) with pH as indicated. The initial concentration of S-2302 was 1
mM. 100% activity corresponds to maximal activity obtained in each
experiment.
Table III. Effect of inhibitors on recombinant human tissue
kallikrein protein (hK)5 and hK14
Inhibitor hK5 IC50 (lM) hK14 IC50 (lM)
Aprotinin 3 3
ZnSO4 4 2
Soybean trypsin inhibitor 0.1 0.1
Leupeptin 10 3
Chymostatin 4100 30
Inactivation experiments were performed with enzyme concentration
0.3 mM for hK5 and 1.4 nM for hK14 as described (Egelrud, 1993) but with
no KCl in the reaction mixture. The substrate S-2288 (initial concentration
1.0 mM) was used to measure residual hK5 and hK14 activity. The same
enzyme preparations as in Table II were used.
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enzymes by treatment with trypsin (Hansson et al, 1994;
Brattsand and Egelrud, 1999). Since trypsin is a very efficient
enzyme and cleaves a wide variety of substrates, and since
it is difficult to efficiently remove all trypsin once it has been
added to a preparation of protease precursor, we explored
alternative means to obtain catalytically active recombinant
hK5 and hK14. For hK5 we produced a mutated precursor
that contained an activation site specifically recognized by
enterokinase, an enzyme with very high substrate specificity
(Huang et al, 1997). In addition to the mutated pro-hK5 we
found that also native pro-hK14 could be efficiently activat-
ed by enterokinase, most likely due to the high functional
amino acid sequence similarity of its activation site to the
natural enterokinase site (see Table IV). Active hK14 was also
obtained by expressing the cDNA for pro-hK14 in yeast
cells, most likely due to the presence of yeast enzymes in
conditioned media that could cleave off the propeptide.
The comparison of the catalytic properties of hK5 and
hK14 toward a set of chromogenic peptide substrates
showed that hK14 was superior to hK5, as regards maxi-
mum catalytic efficiency as well as substrate affinity. When
substrate affinity (Km values) was taken into account, both
skin enzymes were inferior to pancreatic trypsin. From the
figures shown in Table II it can be calculated that, using, e.g.,
S-2288 at ‘‘optimal concentration’’ as substrate, and as-
suming that hK5 and hK14 were the only enzymes present in
an extract to be analyzed, the same contribution to the total
activity measured would be given by hK5 and hK14 at a
concentration of active hK14 two orders of magnitude lower
than that of active hK5. This should be taken into account
when analyzing skin preparations for ‘‘trypsin-like’’ and
‘‘chymotrypsin-like’’ activities (Egelrud and Lundstro¨m,
1991; Egelrud, 1993; Suzuki et al, 1996; Hachem et al,
2003; Komatsu et al, 2003). It should also be noted that if
there is an enzyme in the epidermis with catalytic properties
similar to pancreatic trypsin, which has been suggested,1
this enzyme could be present in very low concentrations and
still play a significant role due to its high catalytic efficiency.
We found that hK5, but not hK14, could act as an ac-
tivator of hK7. This was in spite of the fact that hK14 had
similar primary substrate specificity as hK5, and was a
much more efficient catalyst with other substrates tested. In
addition, hK5 could activate pro-hK14. hK14, on the other
hand, could activate pro-hK5 but not pro-hK14. These re-
sults show that there may be considerable differences
among ‘‘trypsin-like’’ serine proteases produced by the ep-
idermis, which are likely to have implications not only for
activation of protease precursors, but also for the concerted
actions of this group of enzymes on, e.g., structural proteins
in the stratum corneum.
In this respect, the observed effects of pH may also be
relevant. We reported previously that hK5 and hK7 both have
significant activity toward protein substrates at the low pH of
the stratum corneum (Ekholm et al, 2000). In this work we
Table IV. Structures of pro-peptides and cleavage sites of pro-
human tissue kallikrein protein (hK)5, pro-hK7 and pro-hK14
Enzyme Amino acid sequence
pro-hK5 aSerAspAspSerSerSerArg-IleIleAsnGly
proEK-hK5 aSerAspAspAspAspAspLys-IleIleAsnGly
pro-hK7 GluGluAlaGlnGlyAspLys-IleIleAspGlyAla
pro-hK14 GlnGluAspGluAsnLys-IleIleGlyGly
The N-terminal amino acid sequences of active enzymes are shown by
italics.
aOnly the seven amino acids closest to the activation site are shown for
pro-hK5 and the enterokinase mutated proEK-hK5.
Figure 3
Activation of pro-human tissue kallikrein protein (hK)7 by hK5. pro-
hK7, 5 mg, was incubated at room temperature with different amounts
of auto-activated wild-type hK5 in 0.15 M NaCl, 0.1 M NaAc pH 5.6 in a
total volume of 20 mL. Samples, 2.5 mL, were taken for analyses at time
points as indicated. (A) Activity toward S-2586 at 251C (1.2 mM in 0.075
mM Tris-HCl pH 8.0; incubation volume 77.5 mL). The ratio pro-hK7:hK5
was 1:0 (filled squares), 10:1 (open triangles), 3:1 (filled triangles), 1:1
(open circles), and 1:2 (filled circles). (B) Immunoblot of reduced sam-
ples stained with anti-hK7 antibody diluted 1:3000. Samples were tak-
en after 24 h incubation with ratios pro-hK7:hK5 1:0 (lane 1), 3:1 (lane
2), 1:1 (lane 3), and 1:2 (lane 4). The bands in lanes 2–4 from top to
bottom corresponds to (1) glycosylated pro-form, (2) non-glycosylated
pro-form as well as glycosylated active form, and (3) non-glycosylated
active form (Hansson et al, 1994; Ekholm et al, 2000).
Figure4
The effect of pH on the activation rate of pro-kallikreins by kallik-
reins. In a total volume of 12 mL of universal buffer pH 4.5–10 auto-
activated wild-type human tissue kallikrein protein (hK)5 or hK14 pro-
duced in Pichia pastoris was incubated at 371C with pro-enzymes as
follows: (A) hK5, 1 mg and pro-hK7, 3 mg. (B) hK5, 0.5 mg and wild-type
pro-hK5, 5 mg. (C) hK14, 25 ng and wild-type pro-hK5, 4.2 mg. (D) hK5,
1 mg and pro-hK14 (without tag, produced in insect cells), 2.25 mg. After
3 h of incubation, protease activity was measured by mixing 2.5 mL (A,
B, D) or 5 mL (C) of the respective incubation mixture with 75 mL of
chromogenic substrate at 371C (1.2 mM initial concentration S-2586 (A)
or 1 mM S-2302 (B–D) in buffer 0.075 mM Tris-HCl pH 8.0). 100%
activity corresponds to maximal activity obtained in each experiment.
1Nakanishi J, Sato J, Koyama J, Nakayama Y: Expression of
enteropeptidase is restricted in uppermost granular cells in human
epidermis. J Invest Dermatol 110:611, 1998 (abstr).
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found that activation of hK7 and hK14 by hK5 proceeded
faster at acidic pH-values close to those reported for the
stratum corneum (O¨hman and Vahlquist, 1994) than at the
alkaline pH, which was optimal for cleavage of small peptide
substrates by hK5. Auto-activation of hK5, on the other hand,
as well as activation of pro-hK5 by hK14 was optimal at pH
7–9. These differences in effects of pH may eminate from the
specific protein-protein interactions occurring between each
pair of precursor (substrate) and activator (enzyme).
hK7 is responsible for a major part of the total proteolytic
activity in the stratum corneum. hK5 is the only enzyme
found in the epidermis so far that can activate hK7. Since
hK5 can activate also its own precursor as well as pro-
hK14, it may play a key role in a postulated proteolytic
cascade in the stratum corneum, including hK5, hK7, hK14,
and possibly other proteases. Our results allow us to spec-
ulate further on how hK5 and hK7 may be involved in des-
quamation. Precursors of both enzymes are being secreted
to the extracellular space at the transition between the
granular and cornified layers. At the close-to-neutral pH of
the deepest layers of the stratum corneum hK5 undergoes
auto-activation (or activation by other proteases such as
hK14). Active hK5 starts to activate pro-hK7 at a rate,
which, due to the pH tolerance of this reaction, is main-
tained throughout the stratum corneum. Due to the slow
rate of hK7 activation significant amounts of pro-hK7 will
remain also in layers close to the skin surface (Ekholm et al,
2000). As a consequence there will be a concentration gra-
dient of active hK7 between deep and superficial layers of
the stratum corneum, and hence also an increase in the rate
of degradation of intercellular cohesive structures as the
corneocytes move toward the skin surface.
For a further understanding of the role played by pro-
teases in various aspects of epidermal biology and patho-
physiology, expression studies will be insufficient. Individual
enzymes should be studied with regard to their catalytic
properties, and we should learn more about precursor–ac-
tivator relationships among the many proteases now known
to be expressed by epidermal cells.
Materials and Methods
All studies were performed according to Declaration of Helsinki
Principles and approved by the medical ethical committee of the
University of Umea˚.
Production of recombinant hK5 and hK14 Recombinant pro-
hK5 was produced in native form as well as a mutated form with
the activation cleavage site replaced by an enterokinase cleavage
site (Huang et al, 1997). For the native form, a 954 bp KLK5 cDNA
fragment (GenBank AF168768) spanning the entire open reading
frame, including the stop codon and 72 bp upstream of the pu-
tative translation start codon (Brattsand and Egelrud, 1999), was
amplified using the primer pair P12 (50 GTC TCA GCG CAG TGC
CGA TGG T 30)-rLJ4 (50 GAG GAG AAG CCC GGT TCA GGA GTT
GGC CTG GAT GGT TT 30) and inserted into the expression vector
pIZ/V5-His (Invitrogen, Groningen, the Netherlands), resulting in the
plasmid 12N22/pIZ. pro-hK5 with an enterokinase site (proEK-hK5)
was produced by site directed mutagenesis, using the Quick-
change Site-Directed Mutagenesis kit (Stratagene, La Jolla, Cal-
ifornia) with 50 ng of plasmid (12N22/pIZ) as template, and the
primers rEKs (50 GCC CGG TCG GAT GAC GAC GAC GAC AAG
ATC ATC AAT GGA TCC GAC 30) and rEKas (50 GTC GGA TCC ATT
GAT GAT CTT GTC GTC GTC GTC ATC CGA CCG GGC 30). Both
constructs were transfected into High Five cells according to the
user manual InsectSelect System (Invitrogen) and propagated in
High Five Serum-Free medium (Invitrogen).
For production of recombinant pro-hK14 in insect cells a cDNA
containing the coding sequence (Hooper et al, 2001, GenBank
AF283670), including the signal sequence, was amplified from an
RNA-preparation of human epidermis (Brattsand and Egelrud,
1999) using primer pairs KLK14-F1g (50 AGC CCC TAA AAT GGT
CCT CCT GCT 30) and KLK14-as (50 GTC CCG CAT CGT TTC CTC
AAT CC 30) or KLK14-R1 (50 TCA TTT GTC CCG CAT CGT TTC CTC
30) and cloned into the pMT/V5-His-TOPO vector (Invitrogen).
Since the primer KLK14-as did not contain stop codon, the re-
sulting pro-hK14 protein contains V5- and His-tags. The result-
ing constructs were used to transfect Drosophila Schneider 2
cells using the Cellfectin Reagent Kit (Invitrogen). Cells were
co-transfected with the pCoBlast vector (Invitrogen) and stable cell
lines were selected according to instructions in the DES Blasticidin
Support kit (Invitrogen). Stable cell lines were adapted to serum-
free media (Drosophila SFM, Invitrogen) supplemented with 5 mg
per mL blasticidin. Protein expression was induced for 2 wk by
adding 500 mM CuSO4 to the media.
To produce hK14 in yeast cells, the coding sequence of pro-
hK14 without the signal sequence and including the stop codon,
amplified using the primer pair KLK14-F1 (50 CAA GAG GAT GAG
AAC AAG ATA ATT GG 30) and KLK14-R1 (see above), was cloned
into the pPICZaA vector in frame with the a-factor secretion signal
and transformed into Pichia pastoris KM71H using the Easy Comp
Transformation kit (Invitrogen). One liter of BMGY (1% yeast ex-
tract, 2% peptone, 100 mM K2HPO4 pH 6.0, 1.34% yeast nitrogen
base, 4  105% biotin and 1% glycerol) was inoculated and in-
cubated for 3 days. Cells were harvested by centrifugation at
1500  g for 5 min and resuspended in BMMY (as BMGY,
see above, but with 1% methanol instead of glycerol) at a cell
density corresponding to OD600¼ 160. The cells were induced for
72 h, and every 24 h methanol was added to a final concentration
of 1%.
Figure5
Auto-activation of pro-human
tissue kallikrein protein (hK)5
and pro-hK14; activation of
pro-hK5 by hK14. Incubations
were carried out in a total volume
of 30 mL at 371C. At time points as
indicated, samples, 2.5 mL, were
analyzed for protease activity
with 75 mL chromogenic substrate
(initial concentration 1 mM S-2302, in buffer 0.075 mM Tris-HCl pH 8.0).
(A) Wild-type pro-hK5, 15 mg, was incubated in 0.1 M Tris-HCl pH 8.0,
0.15 M NaCl without additions (circles) or with either 1.5 mg of auto-
activated hK5 (diamonds) or 30 ng of Pichia pastoris-produced hK14
(squares). (B) Non-tagged insect cell produced pro-hK14, 10 mg was
incubated in universal buffer pH 6.5, without additions (circles) or with
either 1 mg (squares) or 2.5 mg (diamonds) of auto-activated hK5. (C)
Non-tagged insect cell produced pro-hK14 was incubated in universal
buffer pH 6.5 without additions (circles) or with 1 mg of P. pastoris-
produced hK14 (diamonds). In A ‘‘100% activity’’ was calculated from
the observed activity of hK5 for which auto-activation was judged to be
complete, based on mobility shift on SDS-PAGE (see Fig 1). In B and C
‘‘100% activity’’ was calculated from the activity of corresponding
amounts of yeast-produced hK14.
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The nucleotide sequences of inserts of all constructs were
verified by sequencing using the Big Dye Terminator Cycle
Sequencing kit and analyzed using an ABI377 automated DNA
sequencer (Applied Biosystems, Foster City, California).
Production and purification of recombinant pro-hK7 has been
published (Hansson et al, 1994).
Puriﬁcation of recombinant hK5 and hK14 Recombinant protein
was purified from conditioned cell medium by batch adsorption to
CM Sepharose FF (Amersham Pharmacia Biotech, Freiburg, Ger-
many) followed by reversed phase chromatography (RPC) (Bratt-
sand and Egelrud, 1999). When needed, further purification was
obtained by gel exclusion chromatography followed by a second
run of RPC (Caubet et al, 2004). Purification was considered sat-
isfactory if all components detected by coomassie-stained SDS-
PAGE had the expected molecular mass and were labeled by the
respective specific antibody. Purified proteins were stored at 41C
until use. Before use in activation or kinetic experiments the en-
zymes were transferred to the appropriate buffers with Micro
Biospinn Columns (BioRad Laboratories, Hercules, California).
Mutated pro-hK5 and pro-hK14 produced in insect cells were
activated by treatment with recombinant enterokinase (Novagen,
MERCK Eurolab, Darmstadt, Germany), 0.04 U per mg recombinant
protein, at 371C overnight in 20 mM Tris-HCl pH 8.0, 50 mM NaCl,
2 mM CaCl2. Activated enzymes were stored at 41C after acidi-
fication to pH 4 with 0.5 M HCl.
Protein concentration was determined with the DC Protein As-
say (BioRad). SDS-PAGE and immunoblotting of reduced samples
were performed according to standard protocols. Polyclonal rabbit
antibodies were raised against synthetic peptides; for hK5 a
mixture of RIRPTKDVRPINVSSHC and CEDAYPRQIDDTMF, and
for hK14 a mixture of QEDENKIIGGHTC, CRQVTHPNYNSRTHD,
and CKYRSWIEETMRDK. For hK7 a polyclonal antiserum raised
against rpro-hK7, labeling precursor as well as active enzyme, was
used (Sondell et al, 1996). Extracts of plantar stratum corneum in
acetic acid were prepared as described (Ekholm et al, 2000).
Enzyme activity and kinetics Casein zymography was performed
as described (Horie et al, 1984). Active site titration with a1-an-
titrypsin (SIGMA, St Louis, Missouri) was performed essentially
according to Salvesen and Nagase (1994). Known amounts of bo-
vine pancreatic trypsin (SIGMA, cat. no. T-8253) were used for
standardization. Chromogenic peptide substrates (see Table I for
structures) were purchased from Haemochrom Diagnostica AB
(Mo¨lndal, Sweden). Mixtures containing substrate, enzyme, and
buffer, as specified in legends to tables and figures, were incu-
bated in duplicate or triplicate at 251C or 371C. When the enzyme
under study had been activated with enterokinase, blank values
were obtained from control incubations with the appropriate con-
centrations of enterokinase run in parallel. Km and Vmax were cal-
culated using a Hanes plot. Aprotinin, soybean trypsin inhibitor,
leupeptin, and chymostatin were purchased from Roche (Man-
nheim, Germany).
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